Insulet Corp reports results for the quarter ended December 31 - Earnings Summary

• Insulet Corp PODD.OQ reported quarterly adjusted earnings of $1.15​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $1.40. The mean expectation of twenty one analysts for the quarter was for earnings of $1.02 per share. Wall Street expected results to range from 92 cents to $1.18 per share.

• Revenue rose 17.2% to $597.50 million from a year ago; analysts expected $582.81 million.

• Insulet Corp's reported EPS for the quarter was $1.39​.

• The company reported quarterly net income of $102.9 million.

• Insulet Corp shares had risen by 8.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Insulet Corp is $302.00

This summary was machine generated from LSEG data February 20 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)